These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3515676)

  • 41. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
    Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
    Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sequential conventional immunotherapy with maintenance cyclosporine following renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):69-75. PubMed ID: 3515698
    [No Abstract]   [Full Text] [Related]  

  • 44. Studies of serum beta-2-microglobulin in the initial postoperative period after kidney transplantation.
    Ahlmèn J
    Scand J Urol Nephrol Suppl; 1980; 54():145-9. PubMed ID: 6164092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective serial renal function studies in patients with nonrenal disease treated with cyclosporine A.
    Tegzess AM; Doorenbos BM; Minderhoud JM; Donker AJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):530-3. PubMed ID: 3388497
    [No Abstract]   [Full Text] [Related]  

  • 46. Chronic cyclosporine-associated nephrotoxicity.
    Porter GA; Bennett WM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):204-9. PubMed ID: 3515689
    [No Abstract]   [Full Text] [Related]  

  • 47. The free fraction of cyclosporine in plasma: clinical findings with a new method.
    Lindholm A; Henricsson S; Gang P
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):377-81. PubMed ID: 2834841
    [No Abstract]   [Full Text] [Related]  

  • 48. New Zealand multicentre comparison of monoclonal (Sandimmun) versus polyclonal (cyclosporine-RIA) radioimmunoassays for cyclosporine blood monitoring.
    Cooke R; Wilson T; Tisch G; Rawlins J; Neale TJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1478-81. PubMed ID: 2652474
    [No Abstract]   [Full Text] [Related]  

  • 49. Cyclosporine plasma levels six hours after oral administration. A useful tool for monitoring therapy.
    Cantarovich F; Bizollon C; Cantarovich D; Lefrançois N; Dubernard JM; Traeger J
    Transplantation; 1988 Feb; 45(2):389-94. PubMed ID: 3278433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term effects of short-term cyclosporine.
    Chapman JR; Morris PJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):186-91. PubMed ID: 3515686
    [No Abstract]   [Full Text] [Related]  

  • 51. Conversion from cyclosporine to azathioprine in renal graft recipients.
    MacDonald AS; Belitsky P; Gupta R; Bitter-Suermann H; Campbell R; Cohen A; Lannon SG
    Transplant Proc; 1985 Aug; 17(4):1940-2. PubMed ID: 3895634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous cyclosporine and kidney function: the Johns Hopkins experience.
    Williams GM; Irwin B; Burdick J; Pennington L
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):66-8. PubMed ID: 3515697
    [No Abstract]   [Full Text] [Related]  

  • 53. [Kidney transplantation: posttransplantation monitoring and the immunodepression problems].
    Tomilina NA
    Ter Arkh; 1993; 65(6):82-6. PubMed ID: 8378858
    [No Abstract]   [Full Text] [Related]  

  • 54. Cyclosporine lymphocyte maximum level monitoring in de novo kidney transplant patients: a prospective study.
    Barbari AG; Masri MA; Stephan AG; El Ghoul B; Rizk S; Mourad N; Kamel GS; Kilani HE; Karam AS
    Exp Clin Transplant; 2006 Jun; 4(1):400-5. PubMed ID: 16827634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclosporine A-induced side effects related to a low total serum cholesterol level: an indication for a free cyclosporine A assay?
    de Groen PC; Wiesner RH; Krom RA
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):374-6. PubMed ID: 3284081
    [No Abstract]   [Full Text] [Related]  

  • 56. Cyclosporine blood level and early transplant function of cadaver donor kidneys.
    Hong JH; Sumrani N; Lipkowitz GS; Pilkington BJ; Butt KM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1542-3. PubMed ID: 2652498
    [No Abstract]   [Full Text] [Related]  

  • 57. Effective monitoring and modulation of recipient immune reactivity to prevent rejection in early posttransplant period.
    Thomas F; Mendez-Picon G; Thomas J; Lee HM; Lower R
    Transplant Proc; 1978 Sep; 10(3):537-41. PubMed ID: 362632
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of cyclosporine on the early postoperative function of allografted kidneys with warm ischemic damage.
    Ohshima S; Fujita T; Asano H; Ono Y
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2081-4. PubMed ID: 3547911
    [No Abstract]   [Full Text] [Related]  

  • 59. Diagnostic and prognostic value of donor-specific posttransplant immune responses: clinical correlates and in vitro variables.
    Stiller CR; Sinclair NR; McGirr D; Jevnikar A; Ulan RA
    Transplant Proc; 1978 Sep; 10(3):525-30. PubMed ID: 362629
    [No Abstract]   [Full Text] [Related]  

  • 60. Plasma thrombomodulin levels as an indicator of vascular injury caused by cyclosporine nephrotoxicity.
    Yoshida M; Kozaki M; Ioya N; Kaji N; Tamaki T; Hiraishi S; Ishii H; Kazama M; Fukutomi K; Nagasawa T
    Transplantation; 1990 Dec; 50(6):1066-9. PubMed ID: 2175057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.